1
|
Magnetocardiography study on ventricular depolarization-current pattern in patients with brugada syndrome and complete right-bundle branch blocks.
|
Pacing Clin Electrophysiol
|
2006
|
1.39
|
2
|
Visualization of three-dimensional cardiac electrical excitation using standard heart model and anterior and posterior magnetocardiogram.
|
Int J Cardiovasc Imaging
|
2006
|
1.38
|
3
|
Aging-induced decrease in the PPAR-alpha level in hearts is improved by exercise training.
|
Am J Physiol Heart Circ Physiol
|
2002
|
1.31
|
4
|
Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
|
J Am Coll Cardiol
|
2004
|
1.31
|
5
|
Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo.
|
J Pharmacol Sci
|
2006
|
1.25
|
6
|
Peripartum cardiomyopathy and biventricular thrombi.
|
Circ J
|
2002
|
1.25
|
7
|
Aerobic exercise training reduces plasma endothelin-1 concentration in older women.
|
J Appl Physiol (1985)
|
2003
|
1.14
|
8
|
Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
|
Circulation
|
2004
|
1.04
|
9
|
Effect of age on carotid arterial intima-media thickness in childhood.
|
Heart Vessels
|
2004
|
1.03
|
10
|
Vascular endothelin-B receptor system in vivo plays a favorable inhibitory role in vascular remodeling after injury revealed by endothelin-B receptor-knockout mice.
|
Circulation
|
2002
|
1.03
|
11
|
Stimulation of peroxisome-proliferator-activated receptor alpha (PPAR alpha) attenuates cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts.
|
Clin Sci (Lond)
|
2002
|
1.02
|
12
|
Cardiac hypertrophy by hypertension and exercise training exhibits different gene expression of enzymes in energy metabolism.
|
Hypertens Res
|
2003
|
0.98
|
13
|
The wake of a large vortex is associated with intraventricular filling delay in impaired left ventricles with a pseudonormalized transmitral flow pattern.
|
Echocardiography
|
2006
|
0.92
|
14
|
Peroxisome proliferator-activated receptor-gamma activators inhibit endothelin-1-related cardiac hypertrophy in rats.
|
Clin Sci (Lond)
|
2002
|
0.91
|
15
|
Granulocyte colony-stimulating factor prevents progression of monocrotaline-induced pulmonary arterial hypertension in rats.
|
Circ J
|
2007
|
0.90
|
16
|
Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up.
|
Heart Rhythm
|
2010
|
0.89
|
17
|
Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta 1 and phosphorylated JNK.
|
Am J Physiol Heart Circ Physiol
|
2006
|
0.89
|
18
|
Effect of triangle ventricular pacing on haemodynamics and dyssynchrony in patients with advanced heart failure: a comparison study with conventional bi-ventricular pacing therapy.
|
Eur Heart J
|
2007
|
0.87
|
19
|
Feasibility of targeting catheter ablation to the markedly low-voltage area surrounding infarct scars in patients with post-infarction ventricular tachycardia.
|
Circ J
|
2008
|
0.87
|
20
|
Involvement of endogenous endothelin-1 in exercise-induced redistribution of tissue blood flow: an endothelin receptor antagonist reduces the redistribution.
|
Circulation
|
2002
|
0.85
|
21
|
Volume doubling time of lung cancers detected in a chest radiograph mass screening program: Comparison with CT screening.
|
Oncol Lett
|
2012
|
0.85
|
22
|
The peroxisome proliferator-activated receptor alpha activator fenofibrate inhibits endothelin-1-induced cardiac fibroblast proliferation.
|
J Cardiovasc Pharmacol
|
2004
|
0.84
|
23
|
Association of sleep-disordered breathing and ventricular arrhythmias in patients without heart failure.
|
Am J Cardiol
|
2008
|
0.84
|
24
|
Exercise causes a tissue-specific change of NO production in the kidney and lung.
|
J Appl Physiol (1985)
|
2002
|
0.84
|
25
|
Ventricular fibrillation during anesthesia in association with J waves in the left precordial leads in a child with coarctation of the aorta.
|
J Electrocardiol
|
2003
|
0.84
|
26
|
Activation of peroxisome proliferator-activated receptor-alpha decreases endothelin-1-induced p38 mitogen-activated protein kinase activation in cardiomyocytes.
|
J Cardiovasc Pharmacol
|
2004
|
0.83
|
27
|
Effects of a selective endothelin a receptor antagonist on the expressions of iNOS and eNOS in the heart of early streptozotocin-induced diabetic rats.
|
Exp Biol Med (Maywood)
|
2006
|
0.82
|
28
|
Enhancement of glycolysis in cardiomyocytes elevates endothelin-1 expression through the transcriptional factor hypoxia-inducible factor-1 alpha.
|
Clin Sci (Lond)
|
2002
|
0.82
|
29
|
Altered expression of endothelin, vascular endothelial growth factor, and its receptor in hepatic tissue in endotoxemic rat.
|
Exp Biol Med (Maywood)
|
2006
|
0.82
|
30
|
Down-regulated VEGF expression in the diabetic heart is normalized by an endothelin ETA receptor antagonist.
|
Eur J Pharmacol
|
2006
|
0.82
|
31
|
Exercise training improves cardiac function-related gene levels through thyroid hormone receptor signaling in aged rats.
|
Am J Physiol Heart Circ Physiol
|
2004
|
0.82
|
32
|
Echolucent carotid plaques as a feature in patients with acute coronary syndrome.
|
Circ J
|
2006
|
0.81
|
33
|
Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia.
|
Eur J Clin Pharmacol
|
2006
|
0.81
|
34
|
Alterations in gene expressions encoding preproET-1 and NOS in pulmonary tissue in endotoxemic rats.
|
Exp Biol Med (Maywood)
|
2006
|
0.81
|
35
|
EPA effect on NOS gene expression and on NO level in endothelin-1-induced hypertrophied cardiomyocytes.
|
Exp Biol Med (Maywood)
|
2006
|
0.81
|
36
|
Establishment of hypoxia inducible factor-1alpha overexpressing cells that produce endothelin-1.
|
J Cardiovasc Pharmacol
|
2004
|
0.79
|
37
|
Assessing muscle vasodilation using near-infrared spectroscopy in cardiac patients.
|
Circ J
|
2005
|
0.79
|
38
|
Endothelin receptor antagonist reverses decreased NO system in the kidney in vivo during exercise.
|
Am J Physiol Endocrinol Metab
|
2003
|
0.79
|
39
|
Assessment of serum flecainide trough levels in patients with tachyarrhythmia.
|
J Pharm Pharmacol
|
2005
|
0.78
|
40
|
Gender-associated differences in pharmacokinetics and anti-arrhythmic effects of flecainide in Japanese patients with supraventricular tachyarrhythmia.
|
Eur J Clin Pharmacol
|
2007
|
0.78
|
41
|
Repolarization spatial-time current abnormalities in patients with coronary heart disease.
|
Pacing Clin Electrophysiol
|
2009
|
0.78
|
42
|
Effects of exercise training on expression of endothelin-1 mRNA in the aorta of aged rats.
|
Clin Sci (Lond)
|
2002
|
0.78
|
43
|
[Magnesium in congestive heart failure].
|
Clin Calcium
|
2005
|
0.78
|
44
|
Changes in important apoptosis-related molecules in the endothelin-1-induced hypertrophied cardiomyocytes: effect of the pretreatment with eicosapentaenoic Acid.
|
Exp Biol Med (Maywood)
|
2006
|
0.78
|
45
|
Simultaneous determination of serum flecainide and its metabolites by using high performance liquid chromatography.
|
J Pharm Biomed Anal
|
2004
|
0.78
|
46
|
An increase in right atrial magnetic strength is a novel predictor of recurrence of atrial fibrillation after radiofrequency catheter ablation.
|
Circ J
|
2012
|
0.78
|
47
|
Effects of aging and subsequent exercise training on gene expression of endothelin-1 in rat heart.
|
Clin Sci (Lond)
|
2002
|
0.78
|
48
|
Peak C-reactive protein concentration correlates with left ventricular thrombus formation diagnosed by contrast echocardiographic left ventricular opacification in patients with a first anterior acute myocardial infarction.
|
Circ J
|
2006
|
0.78
|
49
|
Integral value of JT interval in magnetocardiography is sensitive to coronary stenosis and improves soon after coronary revascularization.
|
Circ J
|
2007
|
0.77
|
50
|
Noninvasive recording of his potential using magnetocardiograms.
|
Circ J
|
2003
|
0.77
|
51
|
Preload-dependent variation of the propagation velocity in patients with congestive heart failure.
|
J Am Soc Echocardiogr
|
2004
|
0.77
|
52
|
Effects of nicardipine on coronary, vertebral and renal arterial flows in patients with essential hypertension.
|
Hypertens Res
|
2003
|
0.77
|
53
|
Randomized comparison of cilostazol vs ticlopidine for antiplatelet therapy after coronary stenting.
|
Circ J
|
2005
|
0.77
|
54
|
Chronic administration of an endothelin-A receptor antagonist improves exercise capacity in rats with myocardial infarction-induced congestive heart failure.
|
J Cardiovasc Pharmacol
|
2004
|
0.77
|
55
|
The correlation of irregularities in carotid arterial intima-media thickness with coronary artery disease.
|
Heart Vessels
|
2002
|
0.77
|
56
|
A combination of oral endothelin-A receptor antagonist and oral prostacyclin analogue is superior to each drug alone in ameliorating pulmonary hypertension in rats.
|
J Am Coll Cardiol
|
2002
|
0.76
|
57
|
Alterations of gene expressions of preproET-1 and ET receptors in brains of endotoxemic Sprague-Dawley rats.
|
Exp Biol Med (Maywood)
|
2006
|
0.76
|
58
|
A novel mutation associated with Jervell and Lange-Nielsen syndrome in a Japanese family.
|
Circ J
|
2008
|
0.76
|
59
|
Endothelin antagonism suppresses plasma and cardiac endothelin-1 levels in SHRSPs at the typical hypertensive stage.
|
Exp Biol Med (Maywood)
|
2006
|
0.76
|
60
|
Standard template of adult magnetocardiogram.
|
Ann Noninvasive Electrocardiol
|
2008
|
0.76
|
61
|
Effects of dual endothelin receptor antagonist on antiapoptotic marker Bcl-2 expression in streptozotocin-induced diabetic rats.
|
Exp Biol Med (Maywood)
|
2006
|
0.75
|
62
|
A porcine model of ischemic heart failure produced by chronic placement of a tube in a coronary artery.
|
Eur J Heart Fail
|
2003
|
0.75
|
63
|
Continuous intravenous administration of a low dose of epoprostenol greatly decreased serum concentrations of endothelin-1 in primary pulmonary hypertension--a case report.
|
Angiology
|
2005
|
0.75
|
64
|
[Changes in blood volume in the muscles of the thigh and calf during exercise and recovery and their relationships to exercise tolerance in patients with cardiac disease].
|
J Cardiol
|
2002
|
0.75
|
65
|
The endothelin receptor antagonist ameliorates the hypertensive phenotypes of transgenic hypertensive mice with renin-angiotensin genes and discloses roles of organ specific activation of endothelin system in transgenic mice.
|
Life Sci
|
2004
|
0.75
|
66
|
[Magnetocardiographic diagnosis for myocardial ischemia and arrhythmias].
|
Rinsho Byori
|
2006
|
0.75
|
67
|
Enhanced washout of 99mTc-tetrofosmin in hypertrophic cardiomyopathy: quantitative comparisons with regional 123I-BMIPP uptake and wall thickness determined by MRI.
|
Eur J Nucl Med Mol Imaging
|
2003
|
0.75
|
68
|
YM598, an orally active ET(A) receptor antagonist, ameliorates the progression of cardiopulmonary changes and both-side heart failure in rats with cor pulmonale and myocardial infarction.
|
J Cardiovasc Pharmacol
|
2004
|
0.75
|
69
|
Effects of linear ablation at the isthmus between the tricuspid annulus and inferior vena cava for atrial flutter on autonomic nervous activity: analysis of heart rate variability.
|
Circ J
|
2002
|
0.75
|
70
|
Magnetocardiograms in clinical medicine: unique information on cardiac ischemia, arrhythmias, and fetal diagnosis.
|
Intern Med
|
2005
|
0.75
|
71
|
Addition of spironolactone to an angiotensin-converting enzyme inhibitor decreases lung congestion and edema in Dahl hypertensive rats.
|
Heart Vessels
|
2006
|
0.75
|
72
|
Effects of anti-vasospastic agents in Japanese patients with dilated cardiomyopathy and coronary vasospasm.
|
Jpn Heart J
|
2002
|
0.75
|
73
|
Effect of eicosapentaenoic acid on the different endothelin system components in endothelin-1-induced hypertrophied cardiomyocytes.
|
Exp Biol Med (Maywood)
|
2006
|
0.75
|
74
|
[Combination of oral endothelin-A receptor antagonist and oral prostacyclin analogue is superior to each drug alone in ameliorating pulmonary hypertension in rats].
|
J Cardiol
|
2003
|
0.75
|
75
|
Atrial components contributing to pseudo r' deflection in lead V1 in slow/fast atrioventricular nodal reentrant tachycardia: analysis of the atrial activation sequence by basket catheter isochronal mapping.
|
Circ J
|
2002
|
0.75
|
76
|
Effects of medium-chain triglyceride (MCT) application to SHR on cardiac function, hypertrophy and expression of endothelin-1 mRNA and other genes.
|
J Cardiovasc Pharmacol
|
2004
|
0.75
|
77
|
Magnesium sulphate infusion suppresses the cardiac release of noradrenaline during a handgrip stress test.
|
Can J Cardiol
|
2002
|
0.75
|
78
|
Time course alteration of endothelin-1 gene expression in the heart during exercise and recovery from post-exercise periods in rats.
|
J Cardiovasc Pharmacol
|
2004
|
0.75
|
79
|
Comparison of the effect of the ATP-sensitive potassium channel opener YM934 with that of nitroglycerin on impaired coronary circulation in dogs.
|
Int Heart J
|
2005
|
0.75
|
80
|
Noninvasive diagnosis of partial atrial standstill using magnetocardiograms.
|
Circ J
|
2002
|
0.75
|
81
|
Differential effects of selective endothelin type a receptor antagonist on the gene expression of vascular endothelial growth factor and its receptors in streptozotocin-induced diabetic heart.
|
Exp Biol Med (Maywood)
|
2006
|
0.75
|
82
|
A case of sinus of Valsalva-right ventricle fistula without a typical aneurysm, and a single origin of the coronary arteries.
|
Int Heart J
|
2005
|
0.75
|
83
|
Assessment of propagation velocity by contrast echocardiography for standardization of color Doppler propagation velocity measurements.
|
J Am Soc Echocardiogr
|
2004
|
0.75
|
84
|
Electrical space-time abnormalities of ventricular depolarization in patients with Brugada syndrome and patients with complete right-bundle branch blocks studied by magnetocardiography.
|
Pacing Clin Electrophysiol
|
2006
|
0.75
|
85
|
Endothelin-1-induced cardiomyocyte hypertrophy is partly regulated by transcription factor II-F interacting C-terminal domain phosphatase of RNA polymerase II.
|
Life Sci
|
2012
|
0.75
|
86
|
A slight increase of fasting plasma glucose after 2 years was associated with electrocardiogram changes suggestive of coronary heart disease in normal subjects.
|
Clin Cardiol
|
2005
|
0.75
|
87
|
Liquid chromatographic determination of unbound flecainide in therapeutic drug monitoring.
|
J Pharm Biomed Anal
|
2003
|
0.75
|
88
|
[Magnetocardiograms].
|
Nihon Rinsho
|
2003
|
0.75
|
89
|
Amlodipine improves vascular function in patients with moderate to severe hypertension.
|
J Cardiovasc Pharmacol
|
2003
|
0.75
|
90
|
High performance liquid chromatography for routine monitoring of serum flecainide.
|
J Pharm Biomed Anal
|
2002
|
0.75
|
91
|
Relationship between mitral annular calcification and severity of carotid atherosclerosis in patients with symptomatic ischemic cerebrovascular disease.
|
J Cardiol
|
2005
|
0.75
|
92
|
Effects of endothelin-1 eyedrops on the retina in rats.
|
J Cardiovasc Pharmacol
|
2004
|
0.75
|